Meumann EM, Limmathurotsakul D, Dunachie SJ, Wiersinga WJ, Currie BJ. Burkholderia pseudomallei and melioidosis. Nat Rev Microbiol. 2024;22:155–69. DOIPubMedGoogle Scholar
Limmathurotsakul D, Golding N, Dance DA, Messina JP, Pigott DM, Moyes CL, et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol. 2016;1:15008. DOIGoogle Scholar
Dance DA. Melioidosis as an emerging global problem. Acta Trop. 2000;74:115–9. DOIPubMedGoogle Scholar
Gee JE, Allender CJ, Tuanyok A, Elrod MG, Hoffmaster AR. Burkholderia pseudomallei type G in Western Hemisphere. Emerg Infect Dis. 2014;20:682–4. DOIPubMedGoogle Scholar
Steinmetz I, Wagner GE, Kanyala E, Sawadogo M, Soumeya H, Teferi M, et al. Melioidosis in Africa: time to uncover the true disease load. Trop Med Infect Dis. 2018;3:62. DOIPubMedGoogle Scholar
Allou N, Martinet O, Allyn J, Bouchet B, Jaffar-Bandjee MC, Galas T, et al. Emergence of melioidosis in the Indian Ocean region: two new cases and a literature review. PLoS Negl Trop Dis. 2017;11:e0006018. DOIPubMedGoogle Scholar
Doker TJ, Sharp TM, Rivera-Garcia B, Perez-Padilla J, Benoit TJ, Ellis EM, et al. Contact investigation of melioidosis cases reveals regional endemicity in Puerto Rico. Clin Infect Dis. 2015;60:243–50. DOIPubMedGoogle Scholar
Rodríguez JY, Álvarez-Moreno CA, Cortés JA, Rodríguez GJ, Esquea K, Pinzón H, et al. Melioidosis in Colombia, description of a clinical case and epidemiological considerations [in Spanish]. Biomedica. 2019;39:10–8. DOIPubMedGoogle Scholar
Velôso DS, da Silva SP, de Coelho CMS, Parente JML, Veloso TAE, Lima MM, et al. Emergence of melioidosis in Brazil: a case series. J Med Case Rep. 2023;17:362. DOIPubMedGoogle Scholar
Ojeda-Garmendia A, Castro-Durán SB, Morales-de La Peña C, Ojendis-Ojendis AD, Larios-Serrato V, Meza-Radilla G, et al. Occurrence of Melioidosis in an adult patient in Baja California Sur, México, after Hurricane Norma in October 2023. Am J Trop Med Hyg. 2025;112:1120–2. DOIPubMedGoogle Scholar
Petras JK, Elrod MG, Ty MC, Dawson P, O’Laughlin K, Gee JE, et al. Locally acquired melioidosis linked to environment—Mississippi, 2020–2023. N Engl J Med. 2023;389:2355–62. DOIPubMedGoogle Scholar
Cossaboom CM, Marinova-Petkova A, Strysko J, Rodriguez G, Maness T, Ocampo J, et al. Melioidosis in a resident of Texas with no recent travel history, United States. Emerg Infect Dis. 2020;26:1295–9. DOIPubMedGoogle Scholar
Inglis TJ, Rolim DB, de Queiroz Sousa A. Melioidosis in the Americas. Am J Trop Med Hyg. 2006;75:947–54. DOIPubMedGoogle Scholar
Rolim DB, Lima RXR, Ribeiro AKC, Colares RM, Lima LDQ, Rodríguez-Morales AJ, et al. Melioidosis in South America. Trop Med Infect Dis. 2018;3:60. DOIPubMedGoogle Scholar
Sanchez-Villamil JI, Torres AG. Melioidosis in Mexico, Central America, and the Caribbean. Trop Med Infect Dis. 2018;3:24. DOIPubMedGoogle Scholar
Lichtenegger S, Klugherz I, Wagner GE, Michel J, Mollo B, Sanogo A, et al. Melioidosis in Mali: a retrospective observational study. Lancet Glob Health. 2025;13:e1964–72. DOIPubMedGoogle Scholar
Stone NE, Hall CM, Browne AS, Sahl JW, Hutton SM, Santana-Propper E, et al. Burkholderia pseudomallei in soil, US Virgin Islands, 2019. Emerg Infect Dis. 2020;26:2773–5. DOIPubMedGoogle Scholar
Gee JE, Bower WA, Kunkel A, Petras J, Gettings J, Bye M, et al. Multistate outbreak of melioidosis associated with imported aromatherapy spray. N Engl J Med. 2022;386:861–8. DOIPubMedGoogle Scholar
Brennan S, Thompson JM, Gulvik CA, Paisie TK, Elrod MG, Gee JE, et al. Related melioidosis cases with unknown exposure source, Georgia, USA, 1983–2024. Emerg Infect Dis. 2025;31:1802–6. DOIPubMedGoogle Scholar
Nelson M, Barnes KB, Davies CH, Cote CK, Meinig JM, Biryukov SS, et al. The BALB/c mouse model for the evaluation of therapies to treat infections with aerosolized Burkholderia pseudomallei. Antibiotics (Basel). 2023;12:506. DOIPubMedGoogle Scholar
Ulett GC, Ketheesan N, Hirst RG. Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei. Infect Immun. 2000;68:2034–42. DOIPubMedGoogle Scholar
Gauthier YP, Hagen RM, Brochier GS, Neubauer H, Splettstoesser WD, Finke EJ, et al. Study on the pathophysiology of experimental Burkholderia pseudomallei infection in mice. FEMS Immunol Med Microbiol. 2001;30:53–63. DOIPubMedGoogle Scholar
Ulett GC, Ketheesan N, Clair TW, McElnea CL, Barnes JL, Hirst RG. Analogous cytokine responses to Burkholderia pseudomallei strains contrasting in virulence correlate with partial cross-protection in immunized mice. Infect Immun. 2002;70:3953–8. DOIPubMedGoogle Scholar
Conejero L, Patel N, de Reynal M, Oberdorf S, Prior J, Felgner PL, et al. Low-dose exposure of C57BL/6 mice to Burkholderia pseudomallei mimics chronic human melioidosis. Am J Pathol. 2011;179:270–80. DOIPubMedGoogle Scholar
Limmathurotsakul D, Funnell SG, Torres AG, Morici LA, Brett PJ, Dunachie S, et al.; Steering Group on Melioidosis Vaccine Development. Consensus on the development of vaccines against naturally acquired melioidosis. Emerg Infect Dis. 2015;21:e141480. DOIPubMedGoogle Scholar
Cote CK, Mlynek KD, Klimko CP, Biryukov SS, Mou S, Hunter M, et al. Virulence of Burkholderia pseudomallei ATS2021 unintentionally imported to United States in aromatherapy spray. Emerg Infect Dis. 2024;30:2056–69. DOIPubMedGoogle Scholar
Bearss JJ, Hunter M, Dankmeyer JL, Fritts KA, Klimko CP, Weaver CH, et al. Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 mice. PLoS One. 2017;12:e0172627. DOIPubMedGoogle Scholar
Trevino SR, Klimko CP, Reed MC, Aponte-Cuadrado MJ, Hunter M, Shoe JL, et al. Disease progression in mice exposed to low-doses of aerosolized clinical isolates of Burkholderia pseudomallei. PLoS One. 2018;13:e0208277. DOIPubMedGoogle Scholar
Klimko CP, Treviño SR, Moreau AM, Cuadrado MJA, Meyer JR, Fetterer DP, et al. The impact of age and sex on mouse models of melioidosis. Pathogens. 2020;9:113. DOIPubMedGoogle Scholar
Schully KL, Voegtly LJ, Rice GK, Drumm H, Fitzpatrick MC, Malagon F, et al. Phylogenetic and phenotypic characterization of Burkholderia pseudomallei isolates from Ghana reveals a novel sequence type and common phenotypes. Front Microbiol. 2024;15:1401259. DOIPubMedGoogle Scholar
Gee JE, Gulvik CA, Elrod MG, Batra D, Rowe LA, Sheth M, et al. Phylogeography of Burkholderia pseudomallei isolates, Western Hemisphere. Emerg Infect Dis. 2017;23:1133–8. DOIPubMedGoogle Scholar
Cheng JW, Hayden MK, Singh K, Heimler I, Gee JE, Proia L, et al. Burkholderia pseudomallei infection in US traveler returning from Mexico, 2014. Emerg Infect Dis. 2015;21:1884–5. DOIPubMedGoogle Scholar
Pibalpakdee P, Wongratanacheewin S, Taweechaisupapong S, Niumsup PR. Diffusion and activity of antibiotics against Burkholderia pseudomallei biofilms. Int J Antimicrob Agents. 2012;39:356–9. DOIPubMedGoogle Scholar
Welkos SL, Klimko CP, Kern SJ, Bearss JJ, Bozue JA, Bernhards RC, et al. Characterization of Burkholderia pseudomallei strains using a murine intraperitoneal infection model and in vitro macrophage assays. PLoS One. 2015;10:e0124667. DOIPubMedGoogle Scholar
Oduro G, Robberts FJL, Dartey PKA, Owusu-Ofori A, Oppong C, Gyampomah TK, et al. On the environmental presence of Burkholderia pseudomallei in south-central Ghana. Appl Environ Microbiol. 2022;88:e0060022. DOIPubMedGoogle Scholar
Taweechaisupapong S, Kaewpa C, Arunyanart C, Kanla P, Homchampa P, Sirisinha S, et al. Virulence of Burkholderia pseudomallei does not correlate with biofilm formation. Microb Pathog. 2005;39:77–85. DOIPubMedGoogle Scholar
Ganesh PS, Vishnupriya S, Vadivelu J, Mariappan V, Vellasamy KM, Shankar EM. Intracellular survival and innate immune evasion of Burkholderia cepacia: improved understanding of quorum sensing-controlled virulence factors, biofilm, and inhibitors. Microbiol Immunol. 2020;64:87–98. DOIPubMedGoogle Scholar
Limmathurotsakul D, Paeyao A, Wongratanacheewin S, Saiprom N, Takpho N, Thaipadungpanit J, et al. Role of Burkholderia pseudomallei biofilm formation and lipopolysaccharide in relapse of melioidosis. Clin Microbiol Infect. 2014;20:O854–6. DOIPubMedGoogle Scholar
Sawasdidoln C, Taweechaisupapong S, Sermswan RW, Tattawasart U, Tungpradabkul S, Wongratanacheewin S. Growing Burkholderia pseudomallei in biofilm stimulating conditions significantly induces antimicrobial resistance. PLoS One. 2010;5:e9196. DOIPubMedGoogle Scholar
Challacombe JF, Stubben CJ, Klimko CP, Welkos SL, Kern SJ, Bozue JA, et al. Interrogation of the Burkholderia pseudomallei genome to address differential virulence among isolates. PLoS One. 2014;9:e115951. DOIPubMedGoogle Scholar
Busch JD, Kaestli M, Mayo M, Roe CC, Vazquez AJ, Choy JL, et al. Melioidosis in goats at a single Australian farm was caused by multiple diverse lineages of Burkholderia pseudomallei present in soil. PLoS Negl Trop Dis. 2024;18:e0012683. DOIPubMedGoogle Scholar
Roe C, Vazquez AJ, Phillips PD, Allender CJ, Bowen RA, Nottingham RD, et al. Multiple phylogenetically-diverse, differentially-virulent Burkholderia pseudomallei isolated from a single soil sample collected in Thailand. PLoS Negl Trop Dis. 2022;16:e0010172. DOIPubMedGoogle Scholar
Sahl JW, Vazquez AJ, Hall CM, Busch JD, Tuanyok A, Mayo M, et al. The effects of signal erosion and core genome reduction on the identification of diagnostic markers. MBio. 2016;7:e00846–16. DOIPubMedGoogle Scholar
DeBord KM, Elrod MG, Hartloge C, Meyer WA III, Swanson BE, Schrodt CA, et al. Seroprevalence of antibodies to Burkholderia pseudomallei in Mississippi gulf coast residents, September 2023. Pathogens. 2025;14:921. DOIPubMedGoogle Scholar
McCormick JB, Sexton DJ, McMurray JG, Carey E, Hayes P, Feldman RA. Human-to-human transmission of Pseudomonas pseudomallei. Ann Intern Med. 1975;83:512–3. DOIPubMedGoogle Scholar
Ngauy V, Lemeshev Y, Sadkowski L, Crawford G. Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II. J Clin Microbiol. 2005;43:970–2. DOIPubMedGoogle Scholar
Howes M, Currie BJ. Melioidosis and activation from latency: the “time bomb” has not occurred. Am J Trop Med Hyg. 2024;111:156–60. DOIPubMedGoogle Scholar
Lewis ERG, Kilgore PB, Mott TM, Pradenas GA, Torres AG. Comparing in vitro and in vivo virulence phenotypes of Burkholderia pseudomallei type G strains. PLoS One. 2017;12:e0175983. DOIPubMedGoogle Scholar
Weehuizen TAF, Birnie E, Ferwerda B, Roelofs JJTH, de Vos AF, Grobusch MP, et al. Differences in inflammation patterns induced by African and Asian Burkholderia pseudomallei isolates in mice. Am J Trop Med Hyg. 2017;96:1365–9. DOIPubMedGoogle Scholar
St John JA, Ekberg JA, Dando SJ, Meedeniya AC, Horton RE, Batzloff M, et al. Burkholderia pseudomallei penetrates the brain via destruction of the olfactory and trigeminal nerves: implications for the pathogenesis of neurological melioidosis. MBio. 2014;5:e00025. DOIPubMedGoogle Scholar
